NANOFH.HE
Price:
$0.988
Market Cap:
$84.64M
Nanoform Finland Oyj provides nanotechnology and drug particle engineering services for the pharmaceutical industry in Europe and the United States. The company provides nanoparticle production services using its proprietary controlled expansion of supercritical solutions technology that enables clients. The company was founded in 2008 and is headquartered in Helsinki, Finland.
Industry
Biotechnology
IPO Date
2020-06-04
Stock Exchange
HEL
Ticker
NANOFH.HE
According to Nanoform Finland Oyj’s latest financial reports and current stock price. The company's current Enterprise Value is 57.37M. This represents a change of -33.61% compared to the average of 86.41M of the last 4 quarters.
The mean historical Enterprise Value of Nanoform Finland Oyj over the last ten years is 190.90M. The current 57.37M Enterprise Value has changed 2.91% with respect to the historical average. Over the past ten years (40 quarters), NANOFH.HE's Enterprise Value was at its highest in in the September 2021 quarter at 512.75M. The Enterprise Value was at its lowest in in the June 2019 quarter at 0.
Average
190.90M
Median
193.85M
Minimum
-35258.00
Maximum
380.27M
Discovering the peaks and valleys of Nanoform Finland Oyj Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 77.57%
Maximum Annual Enterprise Value = 380.27M
Minimum Annual Increase = -594215.06%
Minimum Annual Enterprise Value = -35258.00
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 84.88M | -26.28% |
| 2023 | 115.14M | -37.66% |
| 2022 | 184.69M | -51.43% |
| 2021 | 380.27M | 10.47% |
| 2020 | 344.23M | 77.57% |
| 2019 | 193.85M | -5.72% |
| 2018 | 205.62M | -1.84% |
| 2017 | 209.47M | -594215.06% |
The current Enterprise Value of Nanoform Finland Oyj (NANOFH.HE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
128.24M
5-year avg
221.84M
10-year avg
190.90M
Nanoform Finland Oyj’s Enterprise Value is greater than Herantis Pharma Oyj (50.90M), less than Optomed Oyj (67.75M), greater than Biohit Oyj (51.23M), less than Nexstim Plc (106.71M), greater than Modulight Oyj (52.31M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 50.90M | $51.32M | |
| 67.75M | $71.70M | |
| 51.23M | $53.73M | |
| 106.71M | $104.59M | |
| 52.31M | $49.37M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nanoform Finland Oyj using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Nanoform Finland Oyj or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Nanoform Finland Oyj's Enterprise Value?
What is the highest Enterprise Value for Nanoform Finland Oyj (NANOFH.HE)?
What is the 3-year average Enterprise Value for Nanoform Finland Oyj (NANOFH.HE)?
What is the 5-year average Enterprise Value for Nanoform Finland Oyj (NANOFH.HE)?
How does the current Enterprise Value for Nanoform Finland Oyj (NANOFH.HE) compare to its historical average?